Clinical Trials on Vaccination; Infection in Germany

Total 2732 results

CureVac

Completed

Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults

Rabies

Germany
University Hospital Muenster
Mukoviszidose eV Bonn Germany

Completed

Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients (StaphCI)

Cystic Fibrosis

Austria, Germany
CureVac

Completed

RNActive® Rabies Vaccine (CV7201) in Healthy Adults

Rabies

Germany
BioNTech SE

Recruiting

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers

Tuberculosis

Germany
AiCuris Anti-infective Cures AG
Medpace, Inc.

Recruiting

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (PRIOH-1)

HSV Infection

United States, Italy, Belgium, France, United Kingdom, Germany, Switzerland, Argentina, Australia, Georgia, Greece, Mexico, Israel, Canada
Marylyn Addo
Charite University, Berlin, Germany; University of Cologne; Ludwig-Maximilians... and other collaborators

Completed

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

MERS (Middle East Respiratory Syndrome)

Germany
LimmaTech Biologics AG

Completed

Phase I to Test a New Pneumococcal Vaccine

Pneumonia, Bacterial | Pneumococcal Pneumonia

Germany
Speransa Therapeutics

Terminated

A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins

SARS-CoV-2 Infection

United States, Germany
Bristol-Myers Squibb

Completed

Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)

Hepatitis

Germany
Novartis Vaccines

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects

Seasonal Influenza

Germany
University of Regensburg

Unknown

Immune Monitoring of Hepatitis C Under DAA Therapy (IMHC)

Hepatitis C

Germany
GlaxoSmithKline
Ludwig-Maximilians - University of Munich

Completed

The Effectiveness of Varicella Vaccination in Children in Germany

Varicella (Chickenpox) | Chickenpox Vaccines

Germany
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY)

COVID-19

Germany
Charite University, Berlin, Germany
Rheumazentrum Ruhrgebiet

Unknown

Etanercept (Enbrel) in Ankylosing Spondylitis (Enbrel_AS-2)

Ankylosing Spondylitis

Germany
Charite University, Berlin, Germany
Bristol-Myers Squibb

Unknown

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis (Aba-AS-01)

Ankylosing Spondylitis

Germany
Charite University, Berlin, Germany
Abbott

Unknown

D2E7-Early AS

Ankylosing Spondylitis

Germany
Charite University, Berlin, Germany
Rheumazentrum Ruhrgebiet

Unknown

Etanercept (Enbrel) in Undifferentiated Spondyloarthritis (Enbrel_uSpA-2)

Spondyloarthritis

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 (CYTOCOV-19)

COVID-19

Germany
Charite University, Berlin, Germany

Unknown

Prednisolone in Active Ankylosing Spondylitis (AS)

Ankylosing Spondylitis

Germany
Pfizer

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Encephalitis, Tick-Borne

Germany, Austria, Poland
Corat Therapeutics Gmbh

Recruiting

Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

Covid19

Germany
Charite University, Berlin, Germany
Allergan

Terminated

Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients

Covid19

Germany
Universitätsklinikum Hamburg-Eppendorf
Ludwig-Maximilians - University of Munich; Philipps University Marburg Medical... and other collaborators

Completed

Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19

Covid19

Germany
Bristol-Myers Squibb

Completed

Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

Hepatitis B, Chronic

Germany
Charite University, Berlin, Germany

Recruiting

Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients

Covid19

Germany
Drägerwerk AG & Co. KGaA

Terminated

Dräger COVID-19 Antigen Test Clinical Performance Study

Covid19

Germany
University of Ulm
Novartis

Withdrawn

Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B (EVD)

Hepatitis B, Chronic

Germany
Charité Research Organisation GmbH
Bayer

Terminated

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat (NICCAM)

Covid19

Germany
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

Herpes Zoster

Germany, Canada, United States
Pfizer

Terminated

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds (AEGIS)

Invasive Fungal Infections

Israel, Germany, United States, Belgium
RWTH Aachen University
Philipps University Marburg Medical Center

Completed

Respiratory Muscles After Inspiratory Muscle Training After COVID-19

COVID-19 | Diaphragm Injury

Germany
University of Ulm

Unknown

Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19 (EndoCom)

Communication | Endoscopy

Germany
Charite University, Berlin, Germany
Hoffmann-La Roche

Unknown

Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis

Ankylosing Spondylitis

Germany
Universitätsklinikum Hamburg-Eppendorf
Altona Children's Hospital; Wilhelmstift Children´s Hospital; Helios Mariahilf... and other collaborators

Unknown

COVID-19 Child Health Investigation of Latent Disease in Hamburg (C19CHILD)

Covid19 | SARS-CoV-2

Germany
University of Erlangen-Nürnberg Medical School

Unknown

Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO) (IPCO)

Severe COVID-19

Germany
Heinrich-Heine University, Duesseldorf
Dr. Wetzchewald

Unknown

National Covid-19 Surveillance Physicians (NAT-COV-SURV)

Antibody COVID-19

Germany
University Hospital Tuebingen

Completed

Endoscopic Interventions in Patients With COVID-19

Change; Endoscopy, COVID-19

Germany
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Terminated

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C Infection

HCV Infection

United States, Germany, Netherlands
University Medicine Greifswald

Recruiting

Staphylococcus Aureus Bacteraemia (SAB)-Support-Study (SABOT)

Staphylococcus Aureus Bacteremia

Germany
LMU Klinikum

Completed

Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial)

Cardiovascular Prevention Behaviour

Germany
University of Kiel
University of Luebeck

Recruiting

European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study (ETPR)

CIED Related Infection

Germany, France, Italy, Austria, United Kingdom
University Hospital Tuebingen

Completed

NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression (COVID-19 NGS)

COVID-19

Germany
Gilead Sciences

Completed

Safety Study of Once a Day ART and Opiate Substitute. (3OD)

HIV Infections

Germany
ViiV Healthcare
GlaxoSmithKline

Completed

Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1

HIV Infections

Germany
Boehringer Ingelheim

Completed

Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers

HIV Infections

Germany
University of Wuerzburg
Schering-Plough

Completed

Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C

Hepatitis C, Chronic

Germany
Valneva Austria GmbH

Completed

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Japanese Encephalitis

Australia, United States, Germany
University Hospital, Essen
Federal Ministry of Education and Reserach (BMBF)

Completed

Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)

Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection. | Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors, | HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral...

Germany
University Hospital Tuebingen
University of Giessen; University Hospital Freiburg; Universitätsklinikum Köln; University Hospital Lübeck and other collaborators

Unknown

Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes (BLOOMY-COM)

Septic Shock | Bloodstream Infection

Germany
Bavarian Nordic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees

Smallpox

Germany

3

Subscribe